Editorial
HSP90 inhibitors as a future therapeutic strategy in diabetes-driven atherosclerosis
Inhibidores de HSP90 como futura estrategia terapéutica en la aterosclerosis asociada a diabetes
Manuel Vázquez-Carrera
Departamento de Farmacología, Toxicología y Química Terapéutica, Facultad de Farmacia y Ciencias de la Alimentación, Universidad de Barcelona, Instituto de Biomedicina de la Universidad de Barcelona (IBUB), Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM)-Instituto de Salud Carlos III, Instituto de Investigación-Hospital Sant Joan de Déu
Read
614
Timeswas read the article
183
Total PDF
431
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 December | 16 | 1 | 17 |
| 2024 November | 22 | 3 | 25 |
| 2024 October | 10 | 3 | 13 |
| 2024 September | 11 | 3 | 14 |
| 2024 August | 21 | 6 | 27 |
| 2024 July | 9 | 4 | 13 |
| 2024 June | 13 | 6 | 19 |
| 2024 May | 11 | 7 | 18 |
| 2024 April | 12 | 10 | 22 |
| 2024 March | 12 | 4 | 16 |
| 2024 February | 12 | 7 | 19 |
| 2024 January | 15 | 7 | 22 |
| 2023 December | 12 | 8 | 20 |
| 2023 November | 9 | 5 | 14 |
| 2023 October | 9 | 4 | 13 |
| 2023 September | 10 | 0 | 10 |
| 2023 August | 4 | 7 | 11 |
| 2023 July | 11 | 5 | 16 |
| 2023 June | 6 | 4 | 10 |
| 2023 May | 9 | 2 | 11 |
| 2023 April | 6 | 3 | 9 |
| 2023 March | 12 | 5 | 17 |
| 2023 February | 17 | 5 | 22 |
| 2023 January | 20 | 7 | 27 |
| 2022 December | 25 | 2 | 27 |
| 2022 November | 19 | 8 | 27 |
| 2022 October | 10 | 6 | 16 |
| 2022 September | 15 | 4 | 19 |
| 2022 August | 16 | 12 | 28 |
| 2022 July | 6 | 8 | 14 |
| 2022 June | 5 | 7 | 12 |
| 2022 May | 12 | 4 | 16 |
| 2022 April | 10 | 6 | 16 |
| 2022 March | 10 | 3 | 13 |
| 2022 February | 6 | 6 | 12 |
| 2018 April | 5 | 1 | 6 |
| 2018 March | 3 | 0 | 3 |
Show all